The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy

被引:89
作者
Galldiks, Norbert [1 ,2 ,3 ,4 ]
Law, Ian [5 ]
Pope, Whitney B. [6 ]
Arbizu, Javier [7 ]
Langen, Karl-Josef [2 ,8 ]
机构
[1] Univ Cologne, Dept Neurol, Cologne, Germany
[2] Forschungszentrum Julich, Inst Neurosci & Med, D-52425 Julich, Germany
[3] Univ Cologne, CIO, Cologne, Germany
[4] Univ Bonn, Cologne, Germany
[5] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark
[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA
[7] Univ Navarra, Clin Univ Navarra, Dept Nucl Med, Pamplona, Spain
[8] Univ Aachen, Dept Nucl Med, Aachen, Germany
关键词
PET; FET; MET; FDOPA; Glioma; Temozolomide; Bevacizumab; Immunotherapy; Checkpoint inhibitors; Pseudoprogression; Pseudoresponse; POSITRON-EMISSION-TOMOGRAPHY; RECURRENT MALIGNANT GLIOMA; DYNAMIC F-18-FET PET; HIGH-GRADE GLIOMAS; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; TREATMENT RESPONSE; RADIATION NECROSIS; TEMOZOLOMIDE CHEMOTHERAPY; GLIOBLASTOMA-MULTIFORME; IMAGING PROLIFERATION;
D O I
10.1016/j.nicl.2016.12.020
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-enhanced MRI. However, the capacity of conventional MRI to differentiate tumor tissue from posttherapeutic effects following neurosurgical resection, chemoradiation, alkylating chemotherapy, radiosurgery, and/or immunotherapy may be limited. Metabolic imaging using PET can provide relevant additional information on tumor metabolism, which allows for more accurate diagnostics especially in clinically equivocal situations. This review article focuses predominantly on the amino acid PET tracers C-11-methyl-L-methionine (MET), O-(2-[F-18] fluoroethyl)-L-tyrosine (FET) and 3,4-dihydroxy-6-[F-18]-fluoro-L-phenylalanine (FDOPA) and summarizes investigations regarding monitoring of brain tumor therapy. (C) 2016 The Authors. Published by Elsevier Inc.
引用
收藏
页码:386 / 394
页数:9
相关论文
共 50 条
  • [1] The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI
    Santo, Giulia
    Laudicella, Riccardo
    Linguanti, Flavia
    Nappi, Anna Giulia
    Abenavoli, Elisabetta
    Vergura, Vittoria
    Rubini, Giuseppe
    Sciagra, Roberto
    Arnone, Gaspare
    Schillaci, Orazio
    Minutoli, Fabio
    Baldari, Sergio
    Quartuccio, Natale
    Bisdas, Sotirios
    DIAGNOSTICS, 2022, 12 (04)
  • [2] Repeated amino acid PET imaging for longitudinal monitoring of brain tumors
    Cicone, Francesco
    Galldiks, Norbert
    Papa, Annalisa
    Langen, Karl-Josef
    Cascini, Giuseppe Lucio
    Minniti, Giuseppe
    CLINICAL AND TRANSLATIONAL IMAGING, 2022, 10 (05) : 457 - 465
  • [3] Advantages and limitations of amino acid PET for tracking therapy response in glioma patients
    Langen, Karl-Josef
    Heinzel, Alexander
    Lohmann, Philipp
    Mottaghy, Felix M.
    Galldiks, Norbert
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (02) : 137 - 146
  • [4] Update on amino acid PET of brain tumours
    Langen, Karl-Josef
    Galldiks, Norbert
    CURRENT OPINION IN NEUROLOGY, 2018, 31 (04) : 354 - 361
  • [5] Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
    Galldiks, Norbert
    Langen, Karl-Josef
    FRONTIERS IN NEUROLOGY, 2016, 7
  • [6] Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomas
    Lohmann, Philipp
    Kocher, Martin
    Steger, Jan
    Galldiks, Norbert
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 62 (03) : 272 - 280
  • [7] Diagnostic value of radiolabeled amino acid PET for detection of pseudoprogression of brain tumor after treatment: a meta-analysis
    Kim, Seong-Jang
    Shim, Sung Ryul
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (09) : 965 - 972
  • [8] Amino acid PET monitoring in gliomas
    Roelcke U.
    memo - Magazine of European Medical Oncology, 2015, 8 (2) : 115 - 118
  • [9] Benefit of Static FET PET in Pretreated Pediatric Brain Tumor Patients with Equivocal Conventional MRI Results
    Grosse, Frederik
    Wedel, Florian
    Thomale, Ulrich-Wilhelm
    Steffen, Ingo
    Koch, Arend
    Brenner, Winfried
    Plotkin, Michail
    Driever, Pablo Hernaiz
    KLINISCHE PADIATRIE, 2021, 233 (03): : 127 - 134
  • [10] Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors
    Overcast, Wynton B.
    Davis, Korbin M.
    Ho, Chang Y.
    Hutchins, Gary D.
    Green, Mark A.
    Graner, Brian D.
    Veronesi, Michael C.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (03)